Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani in a Visit to Jebbit Bsharri: We Believe in Transparency and Work to Improve the Performance of Institutions and the Role of the Private and Governmental Hospitals

 
NNA – Deputy Prime Minister Health Minister Ghassan Hasbani visited Jebbit Bsharri accompanied by the Director of his office Michel Aad, Counselors Frederic Eid and Georges Akoury. His first stop was in Al-Arz Medical Center in Qanat where he was greeted by Deputies Sethrida Geagea and Elie Keyrouz, the Lebanese Forces Candidate for the district Joseph Isaac, Head of the Municipality Federation in the District Elie Makhlouf, Head of Qanat Municipality Dr. Antoine Saadeh, members of the Municipality Council and Mayors, President of Cedars Medical Association Rita Garana, the Lebanese Forces coordinators, Heads of centers in Jebbit Bshari, President of Qanat Dispensary Zeina El Alam, member of the Lebanese Dental Association council Joseph El Hayek and a number of Lebanese forces activists , people from the region and nearby villages.
 
Hasbani then announced “the launch of the pilot phase for the telemedicine project that connects the primary healthcare centers to the University hospitals, while providing a gatekeeper model for the health system and high-quality services for the remote villages.” Hasbani also noted the aids granted by the World Bank and UNICEF in this context.

“ We are introducing today from this place this new initiative for the telemedicine pilot phase through electronic devices. This is the first in its kind in Lebanon and the Middle East. This project enables citizens in the healthcare centers in the remote villages to undergo more than 16 medical examinations, and communicate directly with specialist doctors in University Hospitals in Beirut. In the future, they will be able to communicate with specialist doctors abroad, in the event that their case is incurable in Lebanon”, Hasbani said.

Hasbani then headed to Hadath el Jebbeh, before he moved with Geagea and Keyrouz to St. Daniel Dispensary and Hasroun, where he visited the dispensary and the new building of Mar Mema Hospital in Bsharri.

“We believe in transparency and work hard to improve the performance of institutions and the role of Governmental and private hospitals. Our 2025 health strategy includes the introduction of technology in hospitals and the Universal health Coverage for all the citizens, in particular uninsured people.”
 
    1
    ...
ATC Name B/G Ingredients Dosage Form Price
A02AF02 ACTONORM B Aluminium hydroxide - 220mg/5ml, Magnesium hydroxide - 200mg/5ml, Simethicone - 25mg/5ml Suspension 403,153 L.L
A02BC01 ARAPRIDE G Omeprazole - 20mg 20mg Capsule, hard, gastro-resistant 427,342 L.L
A02BC01 AXIPRON G Omeprazole - 20mg 20mg Capsule 373,358 L.L
A03BA01 ATROPINE G Atropine sulfate - 1mg/ml 1mg/ml Injectable solution 702,149 L.L
A03BA01 ATROPINE SULFATE RENAUDIN G Atropine sulfate - 1mg/ml 0.1% Injectable solution 397,777 L.L
A03BA01 ATROPINE I.V. 0.25 MG. G Atropine - 0.25mg/ml 0.25mg/ml Injectable solution 2,412,129 L.L
A03BA01 ATROPINE G Atropine sulfate - 0.5mg/ml 0.5mg/ml Injectable solution 680,315 L.L
A03BA01 ATROPINE SULFATE RENAUDIN G Atropine sulfate - 0.5mg/ml 0.5mg Injectable solution 385,683 L.L
A03BA01 ATROPINE SULFATEAGUETTANT G Atropine - 0.1mg/ml 0.1mg/ml Injectable solution 7,805,376 L.L
A03BB01 ANTIPAN G Hyoscine N butylbromide - 20mg/ml Injectable solution 355,798 L.L
A03BB01 ANTIPAN G Hyoscine N butylbromide - 20mg/ml Injectable solution 2,557,140 L.L
A03E ACTICARBINE G Activated charcoal - 70mg, Papaverine HCl - 14mg Tablet, coated 306,396 L.L
A04AA01 APO-ONDANSETRON G Ondansetron - 8mg 8mg Tablet 1,491,665 L.L
A04AA05 ALOXI B Palonosetron HCl - 0.25mg/5ml 0.25mg/5ml Injectable solution 3,656,595 L.L
A04AA55 AKYNZEO B Palonosetron - 0.5mg, Netupitant - 300mg Capsule, hard 7,364,372 L.L
A04AD12 APREPITANT BIOGARAN 125MG APREPITANT BIOGARAN 80MG G Aprepitant - 125mg, Aprepitant - 80mg 125mg Capsule 2,980,643 L.L
A04AD12 APREPITANT BIOGARAN G Aprepitant - 80mg 80mg Capsule 1,986,199 L.L
A07EC02 ASACOL B Mesalazine - 400mg 400mg Tablet, enteric coated 5,895,437 L.L
A07EC02 ASACOL B Mesalazine - 800mg 800mg Tablet 6,396,690 L.L
A07EC02 ASACOL B Mesalazine - 500mg 500mg Suppository 1,703,992 L.L
A07EC02 ASACOL B Mesalazine - 1g/100ml 1g/100ml Enema 2,748,158 L.L
A07EC02 ASACOL B Mesalazine - 1600mg 1600mg Tablet, modified release 8,454,523 L.L
A07EC02 ASACOL B Mesalazine - 1600mg 1600mg Tablet, modified release 12,310,378 L.L
A10AB01 ACTRAPID BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable solution 752,552 L.L
A10AB01 ACTRAPID BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable solution 752,552 L.L
A10AB06 APIDRA SOLOSTAR BioTech Insulin glulisine - 100IU/ml 100IU/ml Injectable solution 3,942,834 L.L
A10AB06 APIDRA BioTech Insulin glulisine - 100IU/ml 100IU/ml Injectable solution 2,221,372 L.L
A10BB12 AMARYL B Glimepiride - 1mg 1mg Tablet 231,141 L.L
A10BB12 AMEPRIDE G Glimepiride - 1mg 1mg Tablet 137,072 L.L
A10BB12 AMARYL B Glimepiride - 2mg 2mg Tablet 233,829 L.L
    1
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026